Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovene was a major global petrochemical, polymers, and refining company that operated as a subsidiary of BP before being spun off and subsequently acquired. The company specialized in the production of olefins and derivatives, including polyethylene and polypropylene, which are essential components in a vast array of industrial and consumer products. At its peak, Innovene was one of the largest petrochemical companies in the world, with significant manufacturing assets across North America and Europe. In 2005, the company was acquired by the INEOS Group for approximately $9 billion, leading to its integration into INEOS's broader chemical portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovene.